{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:44:01Z","timestamp":1782474241210,"version":"3.54.5"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Laboratory Open Fund of Changsha Maternal and Child Hospital","award":["HPKL2023018"],"award-info":[{"award-number":["HPKL2023018"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872256"],"award-info":[{"award-number":["81872256"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key grant of research and development in Hunan Province","award":["2020DK2002"],"award-info":[{"award-number":["2020DK2002"]}]},{"name":"Natural Science Foundation in Hunan Province","award":["2021JJ30453"],"award-info":[{"award-number":["2021JJ30453"]}]},{"name":"Key project of Hunan Provincial Education Department","award":["19A310"],"award-info":[{"award-number":["19A310"]}]},{"name":"Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province","award":["20134486"],"award-info":[{"award-number":["20134486"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s13402-025-01044-x","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T11:11:08Z","timestamp":1744629068000},"page":"743-760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Exosomes delivering miR-129-5p combined with sorafenib ameliorate hepatocellular carcinoma progression via the KCTD1\/HIF-1\u03b1\/VEGF pathway"],"prefix":"10.1007","volume":"48","author":[{"given":"Xinyu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfeng","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"issue":"1","key":"1044_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hepr.12310","volume":"45","author":"J Muto","year":"2015","unstructured":"J. Muto, K. Shirabe, K. Sugimachi, Y. Maehara, Review of angiogenesis in hepatocellular carcinoma. Hepatol. Res. 45(1), 1\u20139 (2015)","journal-title":"Hepatol. Res."},{"issue":"3","key":"1044_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71(3), 209\u2013249 (2021)","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"1044_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J.F. Blanc, de A.C. Oliveira, A. Santoro, J.L. Raoul, A. Forner et al., Sorafenib in advanced hepatocellular carcinoma. N Engl. J. Med. 359(4), 378\u2013390 (2008)","journal-title":"N Engl. J. Med."},{"issue":"5","key":"1044_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1089\/dna.2007.0662","volume":"27","author":"XF Ding","year":"2008","unstructured":"X.F. Ding, C. Luo, K.Q. Ren, J. Zhang, J.L. Zhou, X. Hu, R.S. Liu, Y. Wang, X. Gao, J. Zhang, Characterization and expression of a human KCTD1 gene containing the BTB domain, which mediates transcriptional repression and homomeric interactions. DNA Cell. Biol. 27(5), 257\u2013265 (2008)","journal-title":"DNA Cell. Biol."},{"issue":"2","key":"1044_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/jcb.22002","volume":"106","author":"X Ding","year":"2009","unstructured":"X. Ding, C. Luo, J. Zhou, Y. Zhong, X. Hu, F. Zhou, K. Ren, L. Gan, A. He, J. Zhu et al., The interaction of KCTD1 with transcription factor AP-2alpha inhibits its transactivation. J. Cell. Biochem. 106(2), 285\u2013295 (2009)","journal-title":"J. Cell. Biochem."},{"issue":"12","key":"1044_CR6","doi-asserted-by":"publisher","first-page":"158514","DOI":"10.1016\/j.bbalip.2019.08.010","volume":"1864","author":"L Pirone","year":"2019","unstructured":"L. Pirone, G. Smaldone, R. Spinelli, M. Barberisi, F. Beguinot, L. Vitagliano, C. Miele, Di S. Gaetano, G.A. Raciti, E. Pedone, KCTD1: a novel modulator of adipogenesis through the interaction with the transcription factor AP2alpha. Biochim. Biophys. Acta Mol. Cell. Biol. Lipids. 1864(12), 158514 (2019)","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"issue":"3","key":"1044_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.devcel.2020.05.026","volume":"54","author":"AG Marneros","year":"2020","unstructured":"A.G. Marneros, AP-2beta\/KCTD1 control Distal Nephron differentiation and protect against Renal Fibrosis. Dev. Cell. 54(3), 348\u2013366e345 (2020)","journal-title":"Dev. Cell."},{"issue":"1","key":"1044_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"D. Hanahan, R.A. Weinberg, The hallmarks of cancer. Cell. 100(1), 57\u201370 (2000)","journal-title":"Cell"},{"issue":"1","key":"1044_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13046-020-01570-6","volume":"39","author":"S Tan","year":"2020","unstructured":"S. Tan, L. Xia, P. Yi, Y. Han, L. Tang, Q. Pan, Y. Tian, S. Rao, L. Oyang, J. Liang et al., Exosomal miRNAs in tumor microenvironment. J. Exp. Clin. Cancer Res. 39(1), 67 (2020)","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1044_CR10","doi-asserted-by":"publisher","first-page":"148874","DOI":"10.1016\/j.gene.2024.148874","volume":"931","author":"Y Wang","year":"2024","unstructured":"Y. Wang, A. Moh-Moh-Aung, T. Wang, M. Fujisawa, T. Ohara, K.I. Yamamoto, M. Sakaguchi, T. Yoshimura, A. Matsukawa, Exosomal delivery of miR-200b-3p suppresses the growth of hepatocellular carcinoma cells by targeting ERG- and VEGF-mediated angiogenesis. Gene. 931, 148874 (2024)","journal-title":"Gene"},{"issue":"5","key":"1044_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"F.J. Slack, A.M. Chinnaiyan, The role of non-coding RNAs in Oncology. Cell. 179(5), 1033\u20131055 (2019)","journal-title":"Cell"},{"issue":"13","key":"1044_CR12","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.7150\/thno.25166","volume":"8","author":"L Yang","year":"2018","unstructured":"L. Yang, J. Qiu, Y. Xiao, X. Hu, Q. Liu, L. Chen, W. Huang, X. Li, L. Li, J. Zhang et al., AP-2\u03b2 inhibits hepatocellular carcinoma invasion and metastasis through slug and snail to suppress epithelial-mesenchymal transition. Theranostics. 8(13), 3707\u20133721 (2018)","journal-title":"Theranostics"},{"issue":"12","key":"1044_CR13","doi-asserted-by":"publisher","first-page":"181006","DOI":"10.1098\/rsos.181006","volume":"5","author":"O Menyhart","year":"2018","unstructured":"O. Menyhart, A. Nagy, B. Gyorffy, Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc. Open. Sci. 5(12), 181006 (2018)","journal-title":"R Soc. Open. Sci."},{"issue":"19","key":"1044_CR14","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.7150\/thno.33800","volume":"9","author":"W Huang","year":"2019","unstructured":"W. Huang, Z. Zhong, C. Luo, Y. Xiao, L. Li, X. Zhang, L. Yang, K. Xiao, Y. Ning, L. Chen et al., The miR-26a\/AP-2alpha\/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma. Theranostics. 9(19), 5497\u20135516 (2019)","journal-title":"Theranostics"},{"issue":"3","key":"1044_CR15","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3892\/ijo.2016.3318","volume":"48","author":"W Huang","year":"2016","unstructured":"W. Huang, C. Chen, Z. Liang, J. Qiu, X. Li, X. Hu, S. Xiang, X. Ding, J. Zhang, AP-2alpha inhibits hepatocellular carcinoma cell growth and migration. Int. J. Oncol. 48(3), 1125\u20131134 (2016)","journal-title":"Int. J. Oncol."},{"issue":"8","key":"1044_CR16","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.biocel.2013.04.024","volume":"45","author":"X Ding","year":"2013","unstructured":"X. Ding, Z. Yang, F. Zhou, F. Wang, X. Li, C. Chen, X. Li, X. Hu, S. Xiang, J. Zhang, Transcription factor AP-2alpha regulates acute myeloid leukemia cell proliferation by influencing Hoxa gene expression. Int. J. Biochem. Cell. Biol. 45(8), 1647\u20131656 (2013)","journal-title":"Int. J. Biochem. Cell. Biol."},{"issue":"12","key":"1044_CR17","doi-asserted-by":"publisher","first-page":"e29043","DOI":"10.1371\/journal.pone.0029043","volume":"6","author":"Y Wu","year":"2011","unstructured":"Y. Wu, Y. Xiao, X. Ding, Y. Zhuo, P. Ren, C. Zhou, J. Zhou, A miR-200b\/200c\/429-Binding site polymorphism in the 3\u2032 untranslated region of the AP-2\u03b1 gene is Associated with Cisplatin Resistance. Plos One. 6(12), e29043 (2011)","journal-title":"Plos One"},{"issue":"9","key":"1044_CR18","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1093\/nar\/gkl319","volume":"34","author":"X Ding","year":"2006","unstructured":"X. Ding, C. Fan, J. Zhou, Y. Zhong, R. Liu, K. Ren, X. Hu, C. Luo, S. Xiao, Y. Wang et al., GAS41 interacts with transcription factor AP-2beta and stimulates AP-2beta-mediated transactivation. Nucleic Acids Res. 34(9), 2570\u20132578 (2006)","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"1044_CR19","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/mc.22646","volume":"56","author":"F Wang","year":"2017","unstructured":"F. Wang, W. Huang, X. Hu, C. Chen, X. Li, J. Qiu, Z. Liang, J. Zhang, L. Li, X. Wang et al., Transcription factor AP-2beta suppresses cervical cancer cell proliferation by promoting the degradation of its interaction partner beta-catenin. Mol. Carcinog. 56(8), 1909\u20131923 (2017)","journal-title":"Mol. Carcinog."},{"issue":"5","key":"1044_CR20","first-page":"3895","volume":"22","author":"L Hu","year":"2020","unstructured":"L. Hu, L. Chen, L. Yang, Z. Ye, W. Huang, X. Li, Q. Liu, J. Qiu, X. Ding, KCTD1 mutants in scalp\u2013ear\u2013nipple syndrome and AP\u20132\u03b1 P59A in Char syndrome reciprocally abrogate their interactions, but can regulate Wnt\/\u03b2\u2013catenin signaling. Mol. Med. Rep. 22(5), 3895\u20133903 (2020)","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"1044_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3892\/ijo.2014.2710","volume":"46","author":"C Chen","year":"2015","unstructured":"C. Chen, Z. Liang, W. Huang, X. Li, F. Zhou, X. Hu, M. Han, X. Ding, S. Xiang, Eps8 regulates cellular proliferation and migration of breast cancer. Int. J. Oncol. 46(1), 205\u2013214 (2015)","journal-title":"Int. J. Oncol."},{"issue":"4","key":"1044_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"D.I. Gabrilovich, S. Ostrand-Rosenberg, V. Bronte, Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12(4), 253\u2013268 (2012)","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"1044_CR23","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/gut.48.4.558","volume":"48","author":"ZW Zhu","year":"2001","unstructured":"Z.W. Zhu, H. Friess, L. Wang, M. Abou-Shady, A. Zimmermann, A.D. Lander, M. Korc, J. Kleeff, M.W. Buchler, Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut. 48(4), 558\u2013564 (2001)","journal-title":"Gut"},{"issue":"8","key":"1044_CR24","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3748\/wjg.v12.i8.1175","volume":"12","author":"L Zhou","year":"2006","unstructured":"L. Zhou, J. Liu, F. Luo, Serum tumor markers for detection of hepatocellular carcinoma. World J. Gastroenterol. 12(8), 1175\u20131181 (2006)","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"1044_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1749-6632.2002.tb04680.x","volume":"973","author":"JP Piret","year":"2002","unstructured":"J.P. Piret, D. Mottet, M. Raes, C. Michiels, CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann. N Y Acad. Sci. 973(1), 443\u2013447 (2002)","journal-title":"Ann. N Y Acad. Sci."},{"issue":"Pt 8","key":"1044_CR26","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1242\/jcs.112.8.1203","volume":"112","author":"D Chilov","year":"1999","unstructured":"D. Chilov, G. Camenisch, I. Kvietikova, U. Ziegler, M. Gassmann, R.H. Wenger, Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alpha. J. Cell. Sci. 112(Pt 8), 1203\u20131212 (1999)","journal-title":"J. Cell. Sci."},{"issue":"10","key":"1044_CR27","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"G.L. Semenza, Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer. 3(10), 721\u2013732 (2003)","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"1044_CR28","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1084\/jem.20100587","volume":"207","author":"CA Corzo","year":"2010","unstructured":"C.A. Corzo, T. Condamine, L. Lu, M.J. Cotter, J.I. Youn, P. Cheng, H.I. Cho, E. Celis, D.G. Quiceno, T. Padhya et al., HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207(11), 2439\u20132453 (2010)","journal-title":"J. Exp. Med."},{"issue":"12","key":"1044_CR29","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"G.L. Wang, B.H. Jiang, E.A. Rue, G.L. Semenza, Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U.S.A. 92(12), 5510\u20135514 (1995)","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5516","key":"1044_CR30","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"M. Ivan, K. Kondo, H. Yang, W. Kim, J. Valiando, M. Ohh, A. Salic, J.M. Asara, W.S. Lane, W.G. Jr. Kaelin, HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 292(5516), 464\u2013468 (2001)","journal-title":"Science"},{"issue":"5516","key":"1044_CR31","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"P. Jaakkola, D.R. Mole, Y.M. Tian, M.I. Wilson, J. Gielbert, S.J. Gaskell, von A. Kriegsheim, H.F. Hebestreit, M. Mukherji, C.J. Schofield et al., Targeting of HIF-alpha to the Von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292(5516), 468\u2013472 (2001)","journal-title":"Science"},{"issue":"46","key":"1044_CR32","doi-asserted-by":"publisher","first-page":"32066","DOI":"10.1074\/jbc.M109.057166","volume":"284","author":"Q Sun","year":"2009","unstructured":"Q. Sun, H. Zhou, N.O. Binmadi, J.R. Basile, Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity. J. Biol. Chem. 284(46), 32066\u201332074 (2009)","journal-title":"J. Biol. Chem."},{"issue":"22","key":"1044_CR33","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.3748\/wjg.v11.i22.3339","volume":"11","author":"YS Zhang","year":"2005","unstructured":"Y.S. Zhang, F.J. Yuan, G.F. Jia, J.F. Zhang, L.Y. Hu, L. Huang, J. Wang, Z.Q. Dai, CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402\/R. World J. Gastroenterol. 11(22), 3339\u20133345 (2005)","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"1044_CR34","doi-asserted-by":"publisher","first-page":"L110","DOI":"10.1152\/ajplung.00423.2016","volume":"312","author":"D Zhang","year":"2017","unstructured":"D. Zhang, H. Lee, Z. Zhu, J.K. Minhas, Y. Jin, Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 312(1), L110\u2013L121 (2017)","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"19","key":"1044_CR35","doi-asserted-by":"publisher","first-page":"2001334","DOI":"10.1002\/advs.202001334","volume":"7","author":"M Zhai","year":"2020","unstructured":"M. Zhai, Y. Zhu, M. Yang, C. Mao, Human mesenchymal stem cell derived exosomes enhance cell-free bone regeneration by altering their miRNAs profiles. Adv. Sci. (Weinh). 7(19), 2001334 (2020)","journal-title":"Adv. Sci. (Weinh)"},{"issue":"4","key":"1044_CR36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.ajhg.2013.03.002","volume":"92","author":"AG Marneros","year":"2013","unstructured":"A.G. Marneros, A.E. Beck, E.H. Turner, M.J. McMillin, M.J. Edwards, M. Field, de N.L. Macena Sobreira, A.B. Perez, J.A. Fortes, A.K. Lampe et al., Mutations in KCTD1 cause scalp-ear-nipple syndrome. Am. J. Hum. Genet. 92(4), 621\u2013626 (2013)","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"1044_CR37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2174\/1874467214666210914122010","volume":"15","author":"S Xu","year":"2022","unstructured":"S. Xu, W. Li, J. Wu, Y. Lu, M. Xie, Y. Li, J. Zou, T. Zeng, H. Ling, The role of miR-129-5p in Cancer: a Novel Therapeutic Target. Curr. Mol. Pharmacol. 15(4), 647\u2013657 (2022)","journal-title":"Curr. Mol. Pharmacol."},{"issue":"11","key":"1044_CR38","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41419-021-04296-1","volume":"12","author":"W Luo","year":"2021","unstructured":"W. Luo, J. Wang, W. Xu, C. Ma, F. Wan, Y. Huang, M. Yao, H. Zhang, Y. Qu, D. Ye et al., LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer. Cell. Death Dis. 12(11), 1043 (2021)","journal-title":"Cell. Death Dis."},{"issue":"1","key":"1044_CR39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12935-022-02754-0","volume":"22","author":"S Ghafouri-Fard","year":"2022","unstructured":"S. Ghafouri-Fard, T. Khoshbakht, B.M. Hussen, S.T. Abdullah, M. Taheri, M. Samadian, A review on the role of mir-16-5p in the carcinogenesis. Cancer Cell. Int. 22(1), 342 (2022)","journal-title":"Cancer Cell. Int."},{"issue":"5","key":"1044_CR40","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/jmcb\/mjw010","volume":"8","author":"H Han","year":"2016","unstructured":"H. Han, W. Li, H. Shen, J. Zhang, Y. Zhu, Y. Li, microRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect. J. Mol. Cell. Biol. 8(5), 400\u2013410 (2016)","journal-title":"J. Mol. Cell. Biol."},{"issue":"1","key":"1044_CR41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13046-019-1188-x","volume":"38","author":"Z Liu","year":"2019","unstructured":"Z. Liu, Y. Wang, L. Wang, B. Yao, L. Sun, R. Liu, T. Chen, Y. Niu, K. Tu, Q. Liu, Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging mir-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 38(1), 194 (2019)","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1044_CR42","doi-asserted-by":"publisher","first-page":"111030","DOI":"10.1016\/j.biopha.2020.111030","volume":"133","author":"Y Zhou","year":"2021","unstructured":"Y. Zhou, Y. Huang, T. Dai, Z. Hua, J. Xu, Y. Lin, L. Han, X. Yue, L. Ho, J. Lu et al., LncRNA TTN-AS1 intensifies sorafenib resistance in hepatocellular carcinoma by sponging mir-16-5p and upregulation of cyclin E1. Biomed. Pharmacother. 133, 111030 (2021)","journal-title":"Biomed. Pharmacother"},{"issue":"38","key":"1044_CR43","doi-asserted-by":"publisher","first-page":"23757","DOI":"10.1016\/S0021-9258(17)31580-6","volume":"269","author":"GL Semenza","year":"1994","unstructured":"G.L. Semenza, P.H. Roth, H.M. Fang, G.L. Wang, Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269(38), 23757\u201323763 (1994)","journal-title":"J. Biol. Chem."},{"issue":"30","key":"1044_CR44","doi-asserted-by":"publisher","first-page":"17771","DOI":"10.1074\/jbc.271.30.17771","volume":"271","author":"BH Jiang","year":"1996","unstructured":"B.H. Jiang, E. Rue, G.L. Wang, R. Roe, G.L. Semenza, Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271(30), 17771\u201317778 (1996)","journal-title":"J. Biol. Chem."},{"issue":"5","key":"1044_CR45","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/s-2000-13212","volume":"26","author":"G Breier","year":"2000","unstructured":"G. Breier, Functions of the VEGF\/VEGF receptor system in the vascular system. Semin Thromb. Hemost. 26(5), 553\u2013559 (2000)","journal-title":"Semin Thromb. Hemost."},{"issue":"6","key":"1044_CR46","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"R.S. Apte, D.S. Chen, N. Ferrara, VEGF in Signaling and Disease: Beyond Discovery and Development. Cell. 176(6), 1248\u20131264 (2019)","journal-title":"Cell"},{"issue":"7","key":"1044_CR47","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.molmed.2011.01.015","volume":"17","author":"P Saharinen","year":"2011","unstructured":"P. Saharinen, L. Eklund, K. Pulkki, P. Bono, K. Alitalo, VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol. Med. 17(7), 347\u2013362 (2011)","journal-title":"Trends Mol. Med."},{"issue":"11","key":"1044_CR48","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1091\/mbc.e04-05-0374","volume":"15","author":"N Pore","year":"2004","unstructured":"N. Pore, S. Liu, H.K. Shu, B. Li, D. Haas-Kogan, D. Stokoe, J. Milanini-Mongiat, G. Pages, D.M. O\u2019Rourke, E. Bernhard et al., Sp1 is involved in akt-mediated induction of VEGF expression through an HIF-1-independent mechanism. Mol. Biol. Cell. 15(11), 4841\u20134853 (2004)","journal-title":"Mol. Biol. Cell."},{"issue":"9","key":"1044_CR49","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","volume":"16","author":"JA Forsythe","year":"1996","unstructured":"J.A. Forsythe, B.H. Jiang, N.V. Iyer, F. Agani, S.W. Leung, R.D. Koos, G.L. Semenza, Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16(9), 4604\u20134613 (1996)","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"1044_CR50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.onc.1206122","volume":"22","author":"D Wei","year":"2003","unstructured":"D. Wei, X. Le, L. Zheng, L. Wang, J.A. Frey, A.C. Gao, Z. Peng, S. Huang, H.Q. Xiong, J.L. Abbruzzese et al., Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene. 22(3), 319\u2013329 (2003)","journal-title":"Oncogene"},{"issue":"6733","key":"1044_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"P.H. Maxwell, M.S. Wiesener, G.W. Chang, S.C. Clifford, E.C. Vaux, M.E. Cockman, C.C. Wykoff, C.W. Pugh, E.R. Maher, P.J. Ratcliffe, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399(6733), 271\u2013275 (1999)","journal-title":"Nature"},{"key":"1044_CR52","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.pathol.2.010506.092049","volume":"2","author":"WG Kaelin","year":"2007","unstructured":"W.G. Kaelin, Von Hippel-Lindau disease. Annu. Rev. Pathol. 2, 145\u2013173 (2007)","journal-title":"Annu. Rev. Pathol."},{"key":"1044_CR53","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2017.04.010","volume":"114","author":"C Ngambenjawong","year":"2017","unstructured":"C. Ngambenjawong, H.H. Gustafson, S.H. Pun, Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv. Drug Deliv Rev. 114, 206\u2013221 (2017)","journal-title":"Adv. Drug Deliv Rev."},{"key":"1044_CR54","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2019.05.019","volume":"458","author":"Z Li","year":"2019","unstructured":"Z. Li, T. Wu, B. Zheng, L. Chen, Individualized precision treatment: Targeting TAM in HCC. Cancer Lett. 458, 86\u201391 (2019)","journal-title":"Cancer Lett."},{"key":"1044_CR55","doi-asserted-by":"crossref","unstructured":"L. D\u2019Ignazio, M. Batie, S. Rocha, Hypoxia and inflammation in Cancer, Focus on HIF and NF-kappaB. Biomed. 5(2) (2017)","DOI":"10.3390\/biomedicines5020021"},{"issue":"7519","key":"1044_CR56","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"O.R. Colegio, N.Q. Chu, A.L. Szabo, T. Chu, A.M. Rhebergen, V. Jairam, N. Cyrus, C.E. Brokowski, S.C. Eisenbarth, G.M. Phillips et al., Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 513(7519), 559\u2013563 (2014)","journal-title":"Nature"},{"issue":"11","key":"1044_CR57","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1172\/JCI126923","volume":"130","author":"J Baier","year":"2020","unstructured":"J. Baier, M. Gansbauer, C. Giessler, H. Arnold, M. Muske, U. Schleicher, S. Lukassen, A. Ekici, M. Rauh, C. Daniel et al., Arginase impedes the resolution of colitis by altering the microbiome and metabolome. J. Clin. Invest. 130(11), 5703\u20135720 (2020)","journal-title":"J. Clin. Invest."},{"key":"1044_CR58","doi-asserted-by":"crossref","unstructured":"Y. Wang, M. Fu, J. Wang, J. Zhang, X. Han, Y. Song, Y. Fan, K. Hu, J. Zhou, J. Ge, Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF-1alpha-Dependent and Independent Mechanisms in Heart Failure Rats after Acute Myocardial Infarction. Biomed Res Int. 2020, 1276195 (2020)","DOI":"10.1155\/2020\/1276195"},{"issue":"3","key":"1044_CR59","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1167\/iovs.13-13345","volume":"55","author":"F Mouriaux","year":"2014","unstructured":"F. Mouriaux, F. Sanschagrin, C. Diorio, S. Landreville, F. Comoz, E. Petit, M. Bernaudin, A.P. Rousseau, D. Bergeron, M. Morcos, Increased HIF-1alpha expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma. Investig. Ophthalmol. Vis. Sci. 55(3), 1277\u20131283 (2014)","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"24","key":"1044_CR60","doi-asserted-by":"publisher","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","volume":"66","author":"L Liu","year":"2006","unstructured":"L. Liu, Y. Cao, C. Chen, X. Zhang, A. McNabola, D. Wilkie, S. Wilhelm, M. Lynch, C. Carter, Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5. Cancer Res. 66(24), 11851\u201311858 (2006)","journal-title":"Cancer Res."},{"issue":"9","key":"1044_CR61","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.7150\/jca.54566","volume":"12","author":"W Chen","year":"2021","unstructured":"W. Chen, Y. Mao, C. Liu, H. Wu, S. Chen, Exosome in Hepatocellular Carcinoma: an update. J. Cancer. 12(9), 2526\u20132536 (2021)","journal-title":"J. Cancer"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01044-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-025-01044-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-025-01044-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T10:01:58Z","timestamp":1748426518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-025-01044-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1007\/s13402-025-01044-x","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"31 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethical principles and guidelines for Experiments on Animals and HCC tissues of Hunan Normal University (2018-035).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent for the information to be published was gotten from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}